GEN Exclusives

More »

New Products

Whether you are searching for a DNA purification kit or outfitting a cGMP facility, GEN’s comprehensive new product database is your first and only stop. Conveniently categorized and searchable, the database covers the latest innovations from industry-leading suppliers.

GE Healthcare Life Sciences

  • Page 1 of 1 (4 items) 1 

Accessories for Protein Purification System

GE Healthcare Life Sciences

A fraction collector and sample pump are now available for ÄKTA™ pure, the modular chromatography system for protein purification. Designed to handle both air and liquid, the sample pump, together with the sample inlet valve, provides automate...

Molecular Interaction Software Update

GE Healthcare Life Sciences

Biacore™ T200 Software v.2.0 enhances the capabilities of Biacore T200, offering researchers a tool for processing molecular interaction data. Together, they can facilitate label-free screening of low-molecular-weight compounds and low-abundance pr...

Protein Purification System

GE Healthcare Life Sciences

ÄKTA start is designed to provide automated control of protein purification procedures, allowing the implementation of techniques such as affinity, ion exchange, desalting, and buffer exchange, and gel filtration. The system can support purifi...

Expansion Medium for hMSCs

GE Healthcare Life Sciences

Xuri MSC Medium is a cell culture product that can enable the expansion of human mesenchymal stem cells (hMSC) without the use of animal-derived components or undefined serum. It can be used to culture hMSC from a range of sources including bone...

  • Page 1 of 1 (4 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?